Published in J Transplant on March 18, 2012
Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes Cancer (2013) 1.73
Ginsenoside RK3 Prevents Hypoxia-Reoxygenation Induced Apoptosis in H9c2 Cardiomyocytes via AKT and MAPK Pathway. Evid Based Complement Alternat Med (2013) 0.84
ZFP580, a novel zinc-finger transcription factor, is involved in cardioprotection of intermittent high-altitude hypoxia against myocardial ischemia-reperfusion injury. PLoS One (2014) 0.78
Expression profile analysis based on DNA microarray for patients undergoing off-pump coronary artery bypass surgery. Exp Ther Med (2016) 0.78
Hyperthermia differently affects connexin43 expression and gap junction permeability in skeletal myoblasts and HeLa cells. Mediators Inflamm (2014) 0.77
Differential gene expression pattern in biopsies with renal allograft pyelonephritis and allograft rejection. Clin Transplant (2016) 0.75
Is Local Nitric Oxide Availability Responsible for Myocardial Salvage after Remote Preconditioning? Arq Bras Cardiol (2016) 0.75
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
Myocardial reperfusion injury. N Engl J Med (2007) 13.41
The stress-activated protein kinase subfamily of c-Jun kinases. Nature (1994) 11.45
Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med (2008) 9.40
Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev (1999) 9.02
A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell (1994) 8.52
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol (2003) 6.27
The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation (1977) 5.67
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest (2004) 4.97
An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science (1990) 4.63
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation (2009) 4.61
Postconditioning the human heart. Circulation (2005) 4.35
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet (2007) 3.93
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res (2004) 3.63
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med (2003) 3.45
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation (1993) 3.27
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev (2007) 3.19
Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol (1960) 3.09
Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol (2004) 2.94
Preconditioning the human myocardium. Lancet (1993) 2.93
Myocardial protection by brief ischemia in noncardiac tissue. Circulation (1996) 2.91
Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol (2001) 2.82
Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension (2005) 2.67
Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation (2002) 2.67
The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. J Heart Lung Transplant (2010) 2.43
Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res (2008) 2.37
H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol (2003) 2.31
Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol (2006) 2.30
Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res (2006) 2.30
The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res (1999) 2.27
Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol (2003) 2.26
Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res (2004) 2.25
Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J Biol Chem (2004) 2.24
c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Circ Res (2005) 2.23
Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res (1993) 2.20
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res (2010) 2.20
Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol (2004) 2.18
Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem (2002) 2.05
Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation (2009) 1.94
Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation (1999) 1.93
Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor. J Am Coll Cardiol (2006) 1.89
Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J Biol Chem (1998) 1.87
Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest (1972) 1.86
Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem (1997) 1.84
Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo. J Biol Chem (2005) 1.78
Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant (2009) 1.78
Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem (2001) 1.77
Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res (2008) 1.74
Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res (2000) 1.71
Cardiac allograft vasculopathy: recent developments. Circulation (2008) 1.71
MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation (2004) 1.69
Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ Res (2003) 1.66
Long-term benefit of postconditioning. Circulation (2008) 1.65
Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol Heart Circ Physiol (2005) 1.59
AMP-activated protein kinase as a target for preconditioning in transplantation medicine. Transplantation (2010) 1.59
Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol (1994) 1.58
Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res (2003) 1.57
Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology (2005) 1.55
HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet (1999) 1.53
Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol (2007) 1.52
Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J (2003) 1.51
After four hours of cold ischemia and cardioplegic protocol, the heart can still be rescued with postconditioning. Transplantation (2007) 1.51
Allograft vasculopathy versus atherosclerosis. Circ Res (2006) 1.50
MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J Biol Chem (1999) 1.47
Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene (1998) 1.45
ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol (2009) 1.45
Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol (2008) 1.43
An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem (1999) 1.42
Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol (2004) 1.41
Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? J Mol Cell Cardiol (2009) 1.40
Acute brain death abolishes the cardioprotective effects of ischemic preconditioning in the rabbit. Transplantation (2000) 1.39
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol (2010) 1.37
Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol (2005) 1.37
Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg (2009) 1.36
PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol (1999) 1.35
p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. Circ Res (2002) 1.34
Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol (2004) 1.34
Role of the JAK-STAT pathway in myocardial injury. Trends Mol Med (2006) 1.32
Remote preconditioning protects the heart by activating myocardial PKCepsilon-isoform. Cardiovasc Res (2002) 1.31
Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol (2000) 1.31
Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol (2001) 1.29
Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol (2001) 1.29
A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J Biol Chem (1997) 1.26
p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation (2005) 1.26
Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart (1997) 1.25
Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol (1994) 1.23
Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem J (2002) 1.22
Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol (1997) 1.22
The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J (2000) 1.20
Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg (2004) 1.19
Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation (2009) 1.17
The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg (2005) 1.16
Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation (2005) 1.16
Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop. Circ Res (2007) 1.16
Cardioprotection 'outside the box'--the evolving paradigm of remote preconditioning. Basic Res Cardiol (2003) 1.15
Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis (2006) 1.15
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol (2013) 2.97
Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Ann Intern Med (2007) 2.14
Chronic hypoxia: a model for cyanotic congenital heart defects. J Thorac Cardiovasc Surg (2002) 2.11
Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation (2013) 1.64
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace (2011) 1.64
Arthrobacter woluwensis subacute infective endocarditis: case report and review of the literature. Clin Infect Dis (2004) 1.55
Accuracy and usefulness of fusion imaging between three-dimensional coronary sinus and coronary veins computed tomographic images with projection images obtained using fluoroscopy. Europace (2009) 1.48
Feasibility and acute efficacy of radiofrequency ablation of cavotricuspid isthmus-dependent atrial flutter guided by real-time 3D TEE. JACC Cardiovasc Imaging (2011) 1.42
Anatomy of pulmonary veins by real-time 3D TEE: implications for catheter-based pulmonary vein ablation. JACC Cardiovasc Imaging (2012) 1.38
"In vitro" and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells. J Transl Med (2007) 1.29
Coronary sinus visualization by 3-dimensional real-time echocardiography. J Am Soc Echocardiogr (2007) 1.16
Timing and magnitude of regional right ventricular function: a speckle tracking-derived strain study of normal subjects and patients with right ventricular dysfunction. J Am Soc Echocardiogr (2010) 1.14
Evaluation of the left atrial appendage with real-time 3-dimensional transesophageal echocardiography: implications for catheter-based left atrial appendage closure. Circ Cardiovasc Imaging (2011) 1.14
Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study). Am J Cardiol (2007) 1.10
Hypoxia: unique myocardial morphology? J Thorac Cardiovasc Surg (2004) 1.03
Echocardiographic parameters of mechanical synchrony in healthy individuals. Am J Cardiol (2008) 1.03
Comparison of a non-invasive arterial pulse contour technique and echo Doppler aorta velocity-time integral on stroke volume changes in optimization of cardiac resynchronization therapy. Europace (2010) 1.02
Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail (2008) 1.01
Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets. J Cardiovasc Transl Res (2011) 1.00
Adult human adipose tissue contains several types of multipotent cells. J Cardiovasc Transl Res (2011) 0.99
Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres. J Biomed Biotechnol (2012) 0.97
Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience. JACC Cardiovasc Interv (2011) 0.97
Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol (2008) 0.96
A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice. J Transl Med (2009) 0.95
Hypoxia/reoxygenation cardiac injury and regeneration in zebrafish adult heart. PLoS One (2013) 0.94
Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart (2013) 0.92
Cellular distribution of Hsp70 expression in rat skeletal muscles. Effects of moderate exercise training and chronic hypoxia. Cell Stress Chaperones (2008) 0.90
Cardiac repair with allogeneic mesenchymal stem cells after myocardial infarction. Swiss Med Wkly (2011) 0.89
Chronic in vivo hypoxia in various organs: hypoxia-inducible factor-1alpha and apoptosis. Biochem Biophys Res Commun (2006) 0.89
Magnetic resonance imaging of human endothelial progenitors reveals opposite effects on vascular and muscle regeneration into ischaemic tissues. Cardiovasc Res (2009) 0.88
The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy. Eur Heart J (2008) 0.86
Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products. Am J Transl Res (2010) 0.85
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). Autoimmun Rev (2008) 0.85
Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomography. JACC Cardiovasc Imaging (2008) 0.85
Heart HIF-1alpha and MAP kinases during hypoxia: are they associated in vivo? Exp Biol Med (Maywood) (2007) 0.85
Myocardial tolerance to ischemia-reperfusion injury, training intensity and cessation. Eur J Appl Physiol (2010) 0.84
Redistribution of left ventricular strain by cardiac resynchronization therapy in heart failure patients. Eur J Heart Fail (2010) 0.83
Brief reoxygenation episodes during chronic hypoxia enhance posthypoxic recovery of LV function: role of mitogen-activated protein kinase signaling pathways. Basic Res Cardiol (2006) 0.83
Mitral regurgitation. Swiss Med Wkly (2010) 0.83
The SYNTAX score predicts early mortality risk in the elderly with acute coronary syndrome having primary PCI. J Invasive Cardiol (2011) 0.82
Role of multislice computed tomography for preprocedural evaluation before revision of a chronically implanted transvenous left ventricular lead. Am J Cardiol (2007) 0.82
Comparison of eight echocardiographic methods for determining the prevalence of mechanical dyssynchrony and site of latest mechanical contraction in patients scheduled for cardiac resynchronization therapy. Am J Cardiol (2009) 0.81
Cytochrome c oxidase expression in chronic and intermittent hypoxia rat gastrocnemius muscle quantitated by CE. Electrophoresis (2006) 0.81
Brugada Syndrome and the Subcutaneous Implantable Cardioverter-Defibrillator. J Am Coll Cardiol (2016) 0.81
Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial. Circulation (2005) 0.80
Combined delivery of bone marrow-derived mononuclear cells in chronic ischemic heart disease: rationale and study design. Clin Cardiol (2013) 0.80
Human cardiospheres as a source of multipotent stem and progenitor cells. Stem Cells Int (2013) 0.80
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Thromb Haemost (2014) 0.80
Personality traits, cardiac risk factors, and their association with presence and severity of coronary artery plaque in people with no history of cardiovascular disease. J Cardiovasc Med (Hagerstown) (2014) 0.78
Evaluation of pulmonary atresia with 64-slice multidetector computed tomography (MDCT). Echocardiography (2007) 0.78
Real-time three-dimensional transoesophageal echocardiography showing sequential events of the percutaneous mitral clip procedure. Eur Heart J (2009) 0.78
Combining personality traits with traditional risk factors for coronary stenosis: an artificial neural networks solution in patients with computed tomography detected coronary artery disease. Cardiovasc Psychiatry Neurol (2013) 0.78
Characterization of cardiac-resident progenitor cells expressing high aldehyde dehydrogenase activity. Biomed Res Int (2013) 0.77
Modalities and future prospects of gene therapy in heart transplantation. Eur J Cardiothorac Surg (2009) 0.77
Side-by-side comparison of fluoroscopy, 2D and 3D TEE during percutaneous edge-to-edge mitral valve repair. JACC Cardiovasc Imaging (2012) 0.77
Role of real-time three dimensional transoesophageal echocardiography as guidance imaging modality during catheter based edge-to-edge mitral valve repair. Heart (2013) 0.76
Pulmonary vein isolation guided by real-time three-dimensional transesophageal echocardiography. Pacing Clin Electrophysiol (2011) 0.76
Influence of left atrial and ventricular volumes on the relation between mitral valve annulus and coronary sinus. Am J Cardiol (2008) 0.75
Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial. EuroIntervention (2010) 0.75
Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function. J Transl Med (2014) 0.75
Assessment of coronary stenosis, plaque burden and remodeling by multidetector computed tomography in patients referred for suspected coronary artery disease. J Cardiovasc Med (Hagerstown) (2011) 0.75
Biological markers to predict cardiac resynchronization therapy effect. Circ J (2014) 0.75
Real-time 3-dimensional transesophageal echocardiography during double percutaneous mitral edge-to-edge procedure. JACC Cardiovasc Imaging (2009) 0.75
Complications of percutaneous edge-to-edge mitral valve repair: the role of real-time three-dimensional transesophageal echocardiography. J Am Soc Echocardiogr (2010) 0.75
Acute coronary syndrome following a recent Bentall-De Bono procedure. Eur Heart J (2008) 0.75
Autologous bone marrow mononucleated cell preparation for the clinical treatment of acute myocardial infarction and peripheral arterial disease. Cytotherapy (2011) 0.75
Cardiac fibroma mimicking hypertrophic cardiomyopathy: role of magnetic resonance imaging in the differential diagnosis. Int J Cardiol (2011) 0.75
Multidetector computed tomography image of apical left ventricular descending aorta conduit. Heart (2007) 0.75
Aortic root rupture with giant thoracic haematoma: transient improvement after percutaneous closure with ASD-amplatzer device. Eur Heart J (2013) 0.75
Evaluation of a protocol for same-day discharge after radial lounge monitoring in a southern Swiss referral percutaneous coronary intervention centre. J Cardiovasc Med (Hagerstown) (2017) 0.75
PCSK9 inhibitors: an overview on a new promising lipid-lowering therapy. J Cardiovasc Med (Hagerstown) (2016) 0.75
Erratum to: Highlights from the 2014 Lugano Stem Cell Meeting. J Cardiovasc Transl Res (2015) 0.75
Baseline Predictors of Renal Failure in Transcatheter Aortic Valve Implantation. J Invasive Cardiol (2019) 0.75
A European multicentre, randomised study of the MAR-Tyn cobalt chromium tin-coated stent in patients with de novo coronary artery lesions: study design and protocol. EuroIntervention (2010) 0.75
A very late thrombosis in a bioresorbable vascular scaffold. EuroIntervention (2015) 0.75
Stem cell update: highlights from the 2010 Lugano Stem Cell Meeting. J Cardiovasc Transl Res (2010) 0.75
3D real-time TEE during pulmonary vein isolation in atrial fibrillation. JACC Cardiovasc Imaging (2014) 0.75
Dipyridamole stress echocardiography stratifies outcomes of asymptomatic patients with recent myocardial revascularization. Int J Cardiovasc Imaging (2007) 0.75
Dislodgement of an Amplatzer occluder device causing iatrogenic pulmonary embolism in a patient with post-infarction ventricular septal defect. Eur Heart J (2008) 0.75
Gender in the ACCESS-EU registry: a prospective, multicentre, non-randomised post-market approval study of MitraClip® therapy in Europe. EuroIntervention (2016) 0.75
Type B aortic dissection in a patient with unknown left ventricular non-compaction cardiomyopathy: cardiovascular magnetic resonance diagnosis. Int J Cardiol (2008) 0.75
Abnormal right atrial pouch in a patient with heart failure and cavotricuspid isthmus-dependent atrial flutter. Heart Rhythm (2010) 0.75
Multidetector computed tomography image of apical left ventricular descending aorta conduit. BMJ Case Rep (2009) 0.75
Persistent left superior vena cava imaged by volume-rendering 3D reconstruction multislice computed tomography. Echocardiography (2007) 0.75